Intracisternal osteogenic protein-1 enhances functional recovery following focal stroke

Author: Kawamata, T.; Ren, J.; Chan, T. C.; Charette, M. & Finklestein, S. P.

Description: Osteogenic protein-1 (OP-1, BMP-7) is a member of the transforming growth factor-beta (TGF-beta) superfamily that selectively induces dendritic outgrowth from cultured neurons. We injected human recombinant OP-1 (1 or 10 micrograms) or vehicle into the cisterna magna of mature male Sprague-Dawley rats 1 and 4 days after focal cerebral infarction induced by middle cerebral artery (MCA) occlusion. OP-1 treatment was associated with a marked enhancement of recovery of sensorimotor function of the impaired forelimb and hindlimb (contralateral to infarcts) as assessed by limb placing tests. This effect appeared to be dose dependent. There was no difference in infarct volume between OP-1 and vehicle-treated rats. The mechanisms of enhanced recovery by intracisternal OP-1 may include promotion of dendritic sprouting in the intact uninjured brain.

Subject headings: Analysis of Variance; Animals; Body Weight; Bone Morphogenetic Protein 7; Bone Morphogenetic Proteins, administration & dosage, therapeutic use; Brain, pathology, physiopathology; Cerebral Infarction, drug therapy, physiopathology; Cisterna Magna; Forelimb; Humans; Ischemic Attack, Transient, drug therapy, physiopathology; Male; Microinjections; Motor Activity, drug effects, physiology; Rats; Rats, Sprague-Dawley; Recombinant Proteins, administration & dosage, therapeutic use; Time Factors; Transforming Growth Factor beta, pharmacology

Publication year: 1998

Journal or book title: Neuroreport

Volume: 9

Issue: 7

Pages: 1441-1445

Find the full text:

Find more like this one (cited by):,16&hl=en

Type: Journal article

Serial number: 3067

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.